Publication | Open Access

An orally available inverse agonist of estrogen-related receptor gamma showed expanded efficacy for the radioiodine therapy of poorly differentiated thyroid cancer

OncologyMedicineThyroid DiseaseThyroid CancerRadiopharmaceutical TherapyRadioiodine TherapyAvailable Inverse AgonistThyroid HormoneEndocrinologyPharmacologyRadiation OncologyNuclear MedicineCancer ResearchEndocrine-related Cancer